These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34018690)

  • 1. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
    Zhang Z; Xie L; Ju Y; Dai Y
    Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal-phenolic networks for cancer theranostics.
    Liu P; Shi X; Zhong S; Peng Y; Qi Y; Ding J; Zhou W
    Biomater Sci; 2021 Apr; 9(8):2825-2849. PubMed ID: 33688863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.
    Xie L; Li J; Wang L; Dai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1864. PubMed ID: 36333962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances of Metal-Polyphenol Coordination Polymers for Biomedical Applications.
    Qin J; Guo N; Yang J; Chen Y
    Biosensors (Basel); 2023 Jul; 13(8):. PubMed ID: 37622862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
    Mehata AK; Vikas ; Viswanadh MK; Muthu MS
    Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal-phenolic networks: facile assembled complexes for cancer theranostics.
    Xie W; Guo Z; Zhao L; Wei Y
    Theranostics; 2021; 11(13):6407-6426. PubMed ID: 33995665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of metal-phenolic networks in nanomedicine: a review.
    Wang H; Wang D; Yu J; Zhang Y; Zhou Y
    Biomater Sci; 2022 Oct; 10(20):5786-5808. PubMed ID: 36047491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
    Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
    J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor immunomodulatory effects of polyphenols.
    Wang Q; Yang B; Wang N; Gu J
    Front Immunol; 2022; 13():1041138. PubMed ID: 36505462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-Phenolic Networks as Versatile Coating Materials for Biomedical Applications.
    Fan G; Cottet J; Rodriguez-Otero MR; Wasuwanich P; Furst AL
    ACS Appl Bio Mater; 2022 May; ():. PubMed ID: 35535998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-activatable nanomedicine meets cancer theranostics.
    Li H; Feng Y; Luo Q; Li Z; Li X; Gan H; Gu Z; Gong Q; Luo K
    Theranostics; 2023; 13(15):5386-5417. PubMed ID: 37908735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-Based Aggregation-Induced Emission Theranostic Systems.
    Shen H; Xu C; Sun F; Zhao M; Wu Q; Zhang J; Li S; Zhang J; Lam JWY; Tang BZ
    ChemMedChem; 2022 Feb; 17(3):e202100578. PubMed ID: 34837664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Nanoreactors as Emerging Nanoplatforms for Cancer Precise Nanomedicine.
    Li X; Zhao X; Lv R; Hao L; Huo F; Yao X
    Macromol Biosci; 2021 Jun; 21(6):e2000424. PubMed ID: 33811465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen-Bonds-Mediated Nanomedicine: Design, Synthesis, and Applications.
    Chen S; Wu Y; Lortie F; Bernard J; Binder WH; Zhu J
    Macromol Rapid Commun; 2022 Sep; 43(18):e2200168. PubMed ID: 35609317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.